Science
Mechanism of Action
This extract acts through multiple mechanisms to improve skin health. Its primary alkaloid, berberine, effectively suppresses inflammatory cytokines and inhibits T-cell infiltration, thereby reducing inflammation. Berberine also exhibits antimicrobial activity against bacteria such as Propionibacterium acnes, and restricts lipogenesis in sebaceous glands by 63%, suggesting efficacy in acne treatment. Furthermore, the extract demonstrates an antiproliferative effect on keratinocytes by inhibiting DNA replication and cellular proliferation, which is beneficial for conditions characterized by excessive cell turnover. Other alkaloids, including oxyberberine, corytuberine, columbamine, and jatrorrhizine, contribute to its anti-inflammatory profile by inhibiting lipoxygenase, while the overall extract functions as a potent inhibitor of lipid peroxidation.
Research
Clinical Evidence
High confidence10%
Key findings
- 01 Demonstrated statistically significant improvement in symptoms of psoriasis and atopic dermatitis. Reductions in scaling were observed within one week, with optimal therapeutic outcomes achieved through consistent use over several weeks. Side effects were minimal, primarily pruritus, rash, or a burning sensation.
Transparency
Dusting Analysis
While cosmetic suppliers suggest general usage levels between 0.1% and 1%, clinical studies demonstrating statistically significant improvements in inflammatory skin conditions utilize a 10% concentration. Formulations below 0.1% are unlikely to provide meaningful therapeutic benefits for specific skin concerns.
The Formula
Formulation
Safety
Safety Profile
A formal safety assessment by CIR has not been conducted. Topical application is generally well-tolerated, with minimal side effects such as mild pruritus, rash, or burning sensation, and a slight risk of sensitization has been noted in studies on compromised human skin. Oral consumption of Mahonia aquifolium is discouraged for pregnant women due to the berberine content's potential to induce uterine contractions and elevate bilirubin levels; therefore, topical use during pregnancy should be approached with caution due to the lack of specific safety data. Use in children is not recommended as a safe or effective dose has not been established. Individuals with severe liver or kidney issues should avoid its use. It is important to note that while clinical trials with the topical extract reported no photosensitivity, berberine, a key constituent, has been identified in in vitro studies as a weak photosensitizer in water and capable of generating radicals in nonpolar settings, suggesting that exposure to sun or artificial UVA should be contraindicated for topical products containing berberine due to potential phototoxicity.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Mahonia aquifolium extract is a valuable ingredient for addressing inflammatory skin conditions, acne, and providing general skin conditioning, but careful consideration of its potential photosensitivity and pregnancy warnings is essential for precise formulation.
Related
Similar Ingredients
Finding similar ingredients…